Platinum-based compound based on nucleolar stress
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- TIANJIN MEDICAL UNIV
- Publication Date
- 2019-08-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of platinum compounds, and more specifically relates to a class of platinum anti-tumor compounds based on nucleolus stress and the research on anti-tumor effect, reduction of toxic and side effects and overcoming clinical platinum drug resistance. Background technique
[0002] Cancer is a major killer that threatens human beings all the time in today's world, and the research on cancer treatment has very far-reaching practical significance. Platinum antineoplastic drugs are an important class of metal chemotherapeutic drugs, which are used in more than half of chemotherapy methods. The representative drug, cisplatin, has a broad anti-tumor spectrum and strong effect, and has synergistic effects with many anti-tumor drugs without cross-resistance. It has remarkable curative effect on ovarian cancer and testicular cancer. cure rate. However, severe adverse reactions (such as myelosuppression, leukopenia, oto...